Review on the Prospect of SARS-Cov-2 to Play Rhinovirus in the Current World

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new emergent virus identified in late 2019 as the etiological agent behind a mysterious outbreak of pneumonia in Wuhan, China. The World Health Organization (WHO) later named the disease as coronavirus disease 19 (COVID-19) to account for the variety of clinical manifestations associated with SARS-CoV-2 infection. HRV is the most common cause of upper respiratory tract infection (URI); HRVs are now linked to exacerbations of chronic pulmonary disease, asthma development, and, more recently, severe bronchiolitis in infants and children as well as fatal pneumonia in elderly and immunocompromised adults. Since then, various countries have been following different approach to bank the disease, this includes stay at home declaration, avoiding public gathering, restricting public services and schooling, hence; the disease seems getting benign as a result the level of mortality and morbidity seems declining time to time. This gives an insight that the declining pathogenicity of the disease may be finally terminated as a benign communicable disease like common cold though the agent of the disease is different. These reviews entirely focus on predicting the role of Covid-19 in the current world as a public health concern vis-à-vis the traditional common cold